PORT WASHINGTON, N.Y., October 14, 2016 - Pall Life Sciences, a division of global filtration, separation and purification leader Pall Corporation, is pleased to announce the launch of the Kleenpak® Presto sterile connector to be used in a wide range of applications in upstream, downstream, and formulation and filling.


“We launched the Presto genderless sterile connector family in direct response to customer demand for a reliable, robust universal single-use fluid handling solution,” said the company’s President of Single Use Technologies, Mario Philips. “With its intuitive operation and easy to use features – we worked closely on this new generation design with our customers to ensure even greater levels of sterility assurance.”


The Kleenpak Presto sterile connector is a genderless technology for the sterile connection of two fluid paths even in uncontrolled environments. The connectors are available in ¼ in., ? in., ½ in. and ? in. hose barb sizes, and with ½ in. sanitary connections, and are made from Bisphenol-A free polyethersulfone. The connectors can be used for a wide range of applications and are 100% inspected at point of manufacturer with device traceability and serialization linked to this 100% quality control process.


To learn more about Kleenpak Presto single-use genderless connectors, please visit: http://www.pall.com/main/biopharmaceuticals/product.page?lid=iqdrszve


And see them in action here: www.pall.com/presto


Pall Corporation provides critical fluid management solutions to global life sciences and industrial manufacturing customers. The biopharmaceutical division of Pall Life Sciences features an unmatched portfolio of traditional and single-use products with custom service support from R&D to clinical phases to production. Pall is committed to continuously improving bioprocesses to enable users to advance global health with safe, environmentally responsible technologies. Stay up to date with our latest progress at: www.pall.comLinkedInTwitter; and YouTube.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161014005100/en/

White Matter Communications
Beth Willers, 415-905-0324

Pall Life Sciences Marketing
Rebecca Kale

More Biotech Press Releases
Read all the latest news and developments from Pall and keep in touch with industry trends and opinion.
April 2020
Pall joins a consortium led by Oxford University in fast-tracking clinical trials for a COVID-19 vaccine beginning April 2020.